Live from the NIH registry
Studies recruiting near Wilmington right now
Top 25 of 120 recruiting studies, sorted by proximity — each links to its official registry page
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
Brain Tumor, Recurrent, Brain Tumor
N/A
Observational 600 participants sought
Atlantic Brain & Spine — Wilmington, North Carolina (3.8 mi)
· Sponsor: GT Medical Technologies, Inc.
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate
Phase 2
Interventional 1,431 participants sought
Wilmington Health, PLLC — Wilmington, North Carolina (3.8 mi)
· Sponsor: Eli Lilly and Company
A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
HIV Infections
Phase 2
Interventional 186 participants sought
GSK Investigational Site — Wilmington, North Carolina (3.8 mi)
· Sponsor: ViiV Healthcare
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Heart Failure
Phase 3
Interventional 4,200 participants sought
Wilmington Health — Wilmington, North Carolina (3.8 mi)
· Sponsor: Boehringer Ingelheim
A Study Assessing Safety, Tolerability, and Efficacy of INNA-051 in Preventing Respiratory Illness Due to Viral Infections in Healthy Adults 18 to 45 Years of Age
Viral Respiratory Infection, Viral Respiratory Illnesses
Phase 2
Interventional 1,100 participants sought
Accellacare - Wilmington — Wilmington, North Carolina (3.8 mi)
· Sponsor: ENA Respiratory Pty Ltd
Effectiveness and Adverse-effect Switch Evaluation of Xanomeline and Trospium Chloride (KarXT)
Schizophrenia
N/A
Observational 1,500 participants sought
PPD Virtual - PPD - US — Wilmington, North Carolina (3.8 mi)
· Sponsor: Bristol-Myers Squibb
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
Obesity, Overweight
Phase 2
Interventional 360 participants sought
Accellacare - Tradd Court - Wilmington /ID# 282200 — Wilmington, North Carolina (3.8 mi)
· Sponsor: AbbVie
Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response
Arthritis, Psoriatic
Phase 3
Interventional 600 participants sought
Clinical Site — Leland, North Carolina (9.6 mi)
· Sponsor: MoonLake Immunotherapeutics AG
AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight
Obesity
Phase 3
Interventional 1,150 participants sought
Accellacare and KDCILM, LLC — Wilmington, North Carolina (3.8 mi)
· Sponsor: Novo Nordisk A/S
Observational Study to Assess Maternal, Fetal and Infant Outcomes Following Exposure to Rimegepant
Migraine
N/A
Observational 780 participants sought
Evidera, a PPD business unit — Wilmington, North Carolina (3.8 mi)
· Sponsor: Pfizer
IBD Pregnancy Registry
Inflammatory Bowel Disease (IBD)
N/A
Observational 832 participants sought
PPD — Wilmington, North Carolina (3.8 mi)
· Sponsor: CorEvitas
A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With Uncontrolled Gout
Uncontrolled Gout
Phase 3
Interventional 270 participants sought
Cape Fear Arthritis Care, PLLC — Leland, North Carolina (9.6 mi)
· Sponsor: Amgen
Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' Disease
Graves Disease
Phase 3
Interventional 300 participants sought
Site-045 — Wilmington, North Carolina (3.8 mi)
· Sponsor: Biohaven Therapeutics Ltd.
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Atrial Fibrillation (AF)
Phase 3
Interventional 2,500 participants sought
Anthos Investigative Site 9952 — Wilmington, North Carolina (3.8 mi)
· Sponsor: Anthos Therapeutics, Inc.
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
Intracerebral Hemorrhage, Atrial Fibrillation
Phase 3
Interventional 700 participants sought
New Hanover Regional Medical Center — Wilmington, North Carolina (3.8 mi)
· Sponsor: Yale University
Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
Endometrial Carcinoma, Endometrial Clear Cell Adenocarcinoma
Phase 3
Interventional 360 participants sought
Novant Health New Hanover Regional Medical Center — Wilmington, North Carolina (3.8 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
Chronic Kidney Disease
Phase 3
Interventional 7,000 participants sought
Research Site — Wilmington, North Carolina (3.8 mi)
· Sponsor: AstraZeneca
A Global, Multicenter Study to Assess Maternal, Fetal and Infant Outcomes of Exposure to Palynziq® (Pegvaliase) During Pregnancy and Breastfeeding
Phenylketonuria, Maternal
N/A
Observational 50 participants sought
Syneos Health — Wilmington, North Carolina (3.8 mi)
· Sponsor: BioMarin Pharmaceutical
Study to Evaluate Safety, Efficacy and Immunogenicity of Acne mRNA Vaccine in Adults With Moderate to Severe Acne
Acne
Phase 1, Phase 2
Interventional 800 participants sought
Trial Management Associates - Wilmington - Floral Parkway- Site Number : 8400104 — Wilmington, North Carolina (3.8 mi)
· Sponsor: Sanofi Pasteur, a Sanofi Company
MOVE: Tenosynovial Giant Cell Tumor (TGCT) Real-World Participant Experience With Vimseltinib
Tenosynovial Giant Cell Tumor
N/A
Observational 100 participants sought
Synexus Clinical Research, US INC — Wilmington, North Carolina (3.8 mi)
· Sponsor: Deciphera Pharmaceuticals, LLC
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
Obesity, Type 2 Diabetes
Phase 3
Interventional 2,500 participants sought
Accellacare Wilmington — Wilmington, North Carolina (3.8 mi)
· Sponsor: Novo Nordisk A/S
A Study to Assess the Safety, Tolerability, and Immunogenicity of 3 Lots of a Multivalent Pneumococcal Conjugate Vaccine Administered to Adults
Pneumococcal Disease
Phase 3
Interventional 4,670 participants sought
Accellacare - Wilmington — Wilmington, North Carolina (3.8 mi)
· Sponsor: Pfizer
A Study of Ozanimod in Pregnant Women With Ulcerative Colitis and Their Offspring
Ulcerative Colitis
N/A
Observational 1,182 participants sought
PPD Virtual - PPD - US — Wilmington, North Carolina (3.8 mi)
· Sponsor: Bristol-Myers Squibb
SUNOSI® (Solriamfetol) Pregnancy Registry
Narcolepsy, Obstructive Sleep Apnea
N/A
Observational 1,731 participants sought
PPD, Inc. — Wilmington, North Carolina (3.8 mi)
· Sponsor: Axsome Therapeutics, Inc.
Prevail Global Study
Coronary Artery Disease
N/A
Interventional 1,205 participants sought
Novant Health New Hanover Regional Medical Center — Wilmington, North Carolina (3.8 mi)
· Sponsor: Medtronic Vascular